Supriya Lifesci.

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE07RO01027
NSEID: SUPRIYA
BSEID: 543434
View on NSE | View on BSE

INR

881.25

-98.35 (-10.04%)

BSENSE

Jul 06, 02:22 PM

BSE+NSE Vol: 18.09 lacs

{
  "main_header": {
    "sid": 1003587,
    "name": "Supriya Lifesci.",
    "stock_name": "Supriya Lifesci.",
    "full_name": "Supriya Lifescience Ltd",
    "name_url": "stocks-analysis/supriya-lifesci",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "881.25",
    "chg": -98.35,
    "chgp": "-10.04%",
    "dir": -1,
    "prev_price": "979.60",
    "mcapval": "7,092.55 Cr",
    "mcap": "Small Cap",
    "scripcode": 543434,
    "symbol": "SUPRIYA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE07RO01027",
    "curr_date": "Jul 06, 02:22 PM",
    "curr_time": "14:23 PM",
    "last_traded_at": "Jul 06, 02:22 PM IST",
    "bse_nse_vol": "18.09 lacs",
    "exc_status": "Active",
    "traded_date": "Jul 06, 2026",
    "traded_date_str": "2026 07 06",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/supriya-lifesci-1003587-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Supriya Lifescience Ltd Hits Intraday Low Amid Price Pressure on 6 July 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-hits-intraday-low-amid-price-pressure-on-6-july-2026-4090764",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SupriyaLifescie_priceRelatedfactors_4090764.png",
        "date": "2026-07-06 10:32:56",
        "description": "Supriya Lifescience Ltd experienced a notable decline today, touching an intraday low of Rs 894.25, reflecting a sharp price pressure of -8.71%. The stock underperformed its sector and broader market indices, continuing a recent trend of subdued performance amid mixed market sentiment."
      },
      {
        "title": "Supriya Lifescience Ltd Opens 8.12% Lower in Sharp Gap Down as Technicals Point to Further Weakness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-opens-with-significant-gap-down-amid-market-concerns-4090280",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SupriyaLifescie_gapdown_4090280.png",
        "date": "2026-07-06 09:40:46",
        "description": ""
      },
      {
        "title": "Supriya Lifescience Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/supriya-lifescience-ltd-is-rated-buy-4087694",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SupriyaLifescie_mojoScore_4087694.png",
        "date": "2026-07-03 10:10:04",
        "description": "Supriya Lifescience Ltd is rated Buy by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 July 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Supriya Lifescience Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4084022",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SupriyaLifescie_technicaldot_4084022.png",
        "date": "2026-07-02 08:09:24",
        "description": "Supriya Lifescience Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish trend as of early July 2026. Despite a slight dip in the daily price, the stock’s technical indicators present a complex picture, with bullish signals from MACD and moving averages contrasting against bearish RSI readings. This article analyses these developments in detail, placing them in the context of the company’s recent performance and broader market trends."
      },
      {
        "title": "Supriya Lifescience Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-technical-momentum-shifts-signal-bullish-outlook-4080906",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SupriyaLifescie_technicaldot_4080906.png",
        "date": "2026-07-01 08:05:23",
        "description": "Supriya Lifescience Ltd has demonstrated a significant shift in technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by strong signals from key technical indicators such as MACD, moving averages, and Bollinger Bands, suggesting a positive outlook for the small-cap pharmaceutical and biotechnology company amid robust price performance and market returns."
      },
      {
        "title": "Supriya Lifescience Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/supriya-lifescience-ltd-is-rated-buy-4067404",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SupriyaLifescie_mojoScore_4067404.png",
        "date": "2026-06-22 10:10:04",
        "description": "Supriya Lifescience Ltd is rated Buy by MarketsMOJO, with this rating last updated on 29 May 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock’s current position as of 22 June 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Supriya Lifescience Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-technical-momentum-shifts-signal-bullish-outlook-4060477",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SupriyaLifescie_technicaldot_4060477.png",
        "date": "2026-06-18 08:05:23",
        "description": "Supriya Lifescience Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish to a bullish stance as of late May 2026. This transition is underscored by a comprehensive upgrade in its MarketsMOJO Mojo Grade from Sell to Buy, reflecting improved market sentiment and technical indicators despite a recent intraday price decline. Investors and analysts are closely examining the interplay of momentum oscillators, moving averages, and volume trends to assess the stock’s near-term trajectory within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Supriya Lifescience Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-technical-momentum-shifts-signal-bullish-outlook-amid-mixed-indicators-4055208",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SupriyaLifescie_technicaldot_4055208.png",
        "date": "2026-06-16 08:07:26",
        "description": "Supriya Lifescience Ltd has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a recent downgrade in daily price performance, the stock’s longer-term technicals and fundamental outlook suggest a cautiously optimistic stance for investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Supriya Lifescience Ltd’s Volatile Week: -2.11% Price Change Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltds-volatile-week--211-price-change-amid-mixed-market-signals-4051855",
        "imagepath": "",
        "date": "2026-06-13 15:14:53",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Jun 1:</strong> New 52-week and all-time high at Rs.1,072.05 intraday</p>\n                    <p><strong>Jun 2:</strong> Intraday low amid price pressure at Rs.970</p>\n                    <p><strong>Jun 4:</strong> Price recovery with 5.59% gain</p>\n                    <p><strong>Jun 5:</strong> Week closes at Rs.948.30 (-0.40%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.968.70</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.948.30</div><div class=\"stat-change negative\">-2.11%..."
      }
    ],
    "total": 352,
    "sid": "1003587",
    "stock_news_url": "https://www.marketsmojo.com/news/supriya-lifescience-1003587"
  },
  "announcements": [
    {
      "caption": "Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015.",
      "datetime": "04-Jul-2026",
      "details": "Enclosed herewith is the intimation for submission under Regulation 30 of SEBI (LODR) Regulations 2015.",
      "source": "BSE"
    },
    {
      "caption": "Email Communication To Shareholders Regarding Dividend Taxation Provisions.",
      "datetime": "23-Jun-2026",
      "details": "Email Communication to Shareholders regarding Dividend Taxation Provisions.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "20-Jun-2026",
      "details": "Enclosed herewith is the intimation for trading window closure for declaration of Unaudited Financial Results for quarter ending on June 30 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Supriya Lifescience Ltd has declared <strong>50%</strong> dividend, ex-date: 04 Sep 25",
          "dt": "2025-09-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Supriya Lifescience Ltd Hits Intraday Low Amid Price Pressure on 6 July 2026

2026-07-06 10:32:56

Supriya Lifescience Ltd experienced a notable decline today, touching an intraday low of Rs 894.25, reflecting a sharp price pressure of -8.71%. The stock underperformed its sector and broader market indices, continuing a recent trend of subdued performance amid mixed market sentiment.

Read full news article

Supriya Lifescience Ltd Opens 8.12% Lower in Sharp Gap Down as Technicals Point to Further Weakness

2026-07-06 09:40:46

Read full news article

Supriya Lifescience Ltd is Rated Buy

2026-07-03 10:10:04

Supriya Lifescience Ltd is rated Buy by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 July 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Supriya Lifescience Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-07-02 08:09:24

Supriya Lifescience Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish trend as of early July 2026. Despite a slight dip in the daily price, the stock’s technical indicators present a complex picture, with bullish signals from MACD and moving averages contrasting against bearish RSI readings. This article analyses these developments in detail, placing them in the context of the company’s recent performance and broader market trends.

Read full news article

Supriya Lifescience Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-07-01 08:05:23

Supriya Lifescience Ltd has demonstrated a significant shift in technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by strong signals from key technical indicators such as MACD, moving averages, and Bollinger Bands, suggesting a positive outlook for the small-cap pharmaceutical and biotechnology company amid robust price performance and market returns.

Read full news article

Supriya Lifescience Ltd is Rated Buy

2026-06-22 10:10:04

Supriya Lifescience Ltd is rated Buy by MarketsMOJO, with this rating last updated on 29 May 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock’s current position as of 22 June 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Supriya Lifescience Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-06-18 08:05:23

Supriya Lifescience Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish to a bullish stance as of late May 2026. This transition is underscored by a comprehensive upgrade in its MarketsMOJO Mojo Grade from Sell to Buy, reflecting improved market sentiment and technical indicators despite a recent intraday price decline. Investors and analysts are closely examining the interplay of momentum oscillators, moving averages, and volume trends to assess the stock’s near-term trajectory within the Pharmaceuticals & Biotechnology sector.

Read full news article

Supriya Lifescience Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Mixed Indicators

2026-06-16 08:07:26

Supriya Lifescience Ltd has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a recent downgrade in daily price performance, the stock’s longer-term technicals and fundamental outlook suggest a cautiously optimistic stance for investors in the Pharmaceuticals & Biotechnology sector.